Oppenheimer & Co’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.93M Buy
27,681
+3,875
+16% +$271K 0.03% 585
2025
Q1
$1.75M Sell
23,806
-119
-0.5% -$8.75K 0.03% 583
2024
Q4
$1.57M Buy
23,925
+1,361
+6% +$89.2K 0.02% 630
2024
Q3
$1.76M Buy
22,564
+5,999
+36% +$467K 0.03% 597
2024
Q2
$1.29M Sell
16,565
-1,703
-9% -$133K 0.02% 675
2024
Q1
$1.24M Buy
18,268
+1,694
+10% +$115K 0.02% 664
2023
Q4
$1.12M Buy
16,574
+2,150
+15% +$145K 0.02% 671
2023
Q3
$977K Buy
14,424
+4,919
+52% +$333K 0.02% 685
2023
Q2
$680K Sell
9,505
-916
-9% -$65.6K 0.01% 859
2023
Q1
$723K Sell
10,421
-765
-7% -$53.1K 0.02% 811
2022
Q4
$758K Buy
11,186
+166
+2% +$11.3K 0.02% 772
2022
Q3
$604K Sell
11,020
-3,824
-26% -$210K 0.01% 823
2022
Q2
$980K Buy
14,844
+2,242
+18% +$148K 0.02% 691
2022
Q1
$836K Buy
12,602
+203
+2% +$13.5K 0.02% 811
2021
Q4
$722K Buy
12,399
+295
+2% +$17.2K 0.01% 905
2021
Q3
$727K Sell
12,104
-2,442
-17% -$147K 0.01% 865
2021
Q2
$872K Sell
14,546
-10,239
-41% -$614K 0.02% 804
2021
Q1
$1.23M Buy
24,785
+40
+0.2% +$1.99K 0.02% 638
2020
Q4
$1.24M Sell
24,745
-3,394
-12% -$170K 0.03% 577
2020
Q3
$1.54M Buy
28,139
+13,602
+94% +$745K 0.04% 451
2020
Q2
$768K Buy
14,537
+6,285
+76% +$332K 0.02% 673
2020
Q1
$368K Sell
8,252
-16,217
-66% -$723K 0.01% 835
2019
Q4
$1.22M Sell
24,469
-2,146
-8% -$107K 0.03% 556
2019
Q3
$1.19M Sell
26,615
-338
-1% -$15.1K 0.03% 542
2019
Q2
$1.11M Sell
26,953
-1,054
-4% -$43.5K 0.03% 559
2019
Q1
$1.13M Buy
28,007
+446
+2% +$18K 0.03% 555
2018
Q4
$1.05M Sell
27,561
-9,345
-25% -$355K 0.03% 525
2018
Q3
$1.46M Sell
36,906
-725
-2% -$28.7K 0.04% 482
2018
Q2
$1.32M Buy
37,631
+1,293
+4% +$45.4K 0.04% 499
2018
Q1
$1.27M Buy
36,338
+6,856
+23% +$240K 0.03% 528
2017
Q4
$1.02M Buy
29,482
+13,268
+82% +$460K 0.03% 606
2017
Q3
$550K Buy
16,214
+2,411
+17% +$81.8K 0.01% 813
2017
Q2
$470K Sell
13,803
-5,203
-27% -$177K 0.01% 851
2017
Q1
$592K Buy
19,006
+9,253
+95% +$288K 0.02% 741
2016
Q4
$267K Sell
9,753
-29,718
-75% -$814K 0.01% 1046
2016
Q3
$1.3M Buy
39,471
+9,490
+32% +$312K 0.04% 502
2016
Q2
$906K Buy
29,981
+15,754
+111% +$476K 0.03% 577
2016
Q1
$400K Buy
14,227
+634
+5% +$17.8K 0.01% 833
2015
Q4
$462K Sell
13,593
-1,824
-12% -$62K 0.01% 788
2015
Q3
$491K Buy
15,417
+4,885
+46% +$156K 0.01% 813
2015
Q2
$336K Sell
10,532
-440
-4% -$14K 0.01% 1051
2015
Q1
$376K Buy
10,972
+654
+6% +$22.4K 0.01% 1008
2014
Q4
$363K Sell
10,318
-732
-7% -$25.8K 0.01% 953
2014
Q3
$395K Sell
11,050
-31,836
-74% -$1.14M 0.01% 944
2014
Q2
$1.59M Sell
42,886
-19,102
-31% -$710K 0.05% 444
2014
Q1
$2.01M Sell
61,988
-8,920
-13% -$289K 0.06% 378
2013
Q4
$2.11M Sell
70,908
-20,816
-23% -$618K 0.07% 340
2013
Q3
$2.38M Buy
91,724
+8,280
+10% +$215K 0.08% 291
2013
Q2
$1.97M Buy
+83,444
New +$1.97M 0.08% 310